Rapport Therapeutics shares owned by T. Rowe Price Investment Management
Quarter-by-quarter ownership of Rapport Therapeutics (RAPP) shares owned by T. Rowe Price Investment Management
from 13F filings
Historical chart of T. Rowe Price Investment Management investment in Rapport Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Rapport Therapeutics held by T. Rowe Price Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Rapport Therapeutics by T. Rowe Price Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $21M | 708k | 29.70 |
| 2025-06-30 | $7.0M | 614k | 11.37 |
| 2024-12-31 | $29M | 1.6M | 17.74 |
| 2024-09-30 | $35M | 1.7M | 20.48 |
| 2024-06-30 | $36M | 1.5M | 23.26 |
More positions owned by T. Rowe Price Investment Management
View all positions for T. Rowe Price Investment Management